Table 2.

Summary of clinical characteristics

Clinic indexes	Data
Preoperative screening:
28 preoperative cervical TCT	1 CIN stage III
	3 with atypical squamous cells
	1 inflammation
	2 cervicitis
6 curettage	1 with necrotic tissues and pelvic mass
	1 uterine clear cell carcinoma
	1 endometrial adenocarcinoma
	2 no abnormal tissues
	1 endometrium not found
Pathology:
Type:	1 undifferentiated carcinoma
	1 undifferentiated and transitional cell carcinoma
	34 adenocarcinoma
	24 pure adenocarcinoma
	10 mixed type
Complication:	7 complicated with clear cell carcinoma
	2 complicated with endometrial cancer
	1 complicated with transitional cell carcinoma
Differentiation:	5 moderately differentiated
	29 poorly to moderately, or simply poorly, differentiated
	2 undifferentiated
Sites:	33 unilateral fallopian cancer
	3 bilateral fallopian cancer
	13 with involvement in ovary
	4 with uterine transfer
	3 with myometrial invasion
	1 with endometrial involvement
	14 with pelvic metastasis in omentum
	8 with retroperitoneal lymph node metastasis
Surgical Staging:
Early stage: (47.2%)	4 stage Ia
	5 stage Ic
	2 stage IIa
	1 stage IIb
	5 stage IIc
Advanced Stage: (52.8%)	2 stage IIIb
	17 stage IIIc
Intraoperative residual tumor:	18 with residual tumor
	7 with diameter more than 1 cm
	11 with diameter less than 1 cm
	14 without residual tumor
	4 without records
CA125:	19 had elevated preoperative CA125
	2 stage Ic
	3 stage IIc
	1 stage IIIb
	13 stage IIIc
Follow-up and relapse:
General:	4 drop-outs
	12 with relapse or metastasis (33.3%)
	10 death
	1 stage Ic
	1 stage IIc
	2 stage IIIb
	6 stage IIIc
	2 live with tumor
Sites of relapse:	1 on vaginal stump
	4 with pelvic relapse
	4 with peritoneal relapse
	3 with significantly elevated CA125 yet no lesions found

Abbreviation: CIN, cervical intraepithelial neoplasia.